Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
批准号:
10320993
负责人:
Kartik Chandran
金额:
$230.41万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2024-05-31
关键词:
2019-nCoVAcuteAreaBiological AssayCOVID-19COVID-19 detectionCOVID-19 diagnosticCOVID-19 monitoringCOVID-19 pandemicCOVID-19 riskCOVID-19 surveillanceCOVID-19 testCOVID-19 testingCessation of lifeCharacteristicsCitiesClinicalCollectionCommunitiesConsultCountryCountyDataDetectionDevelopmentDisease OutbreaksEmployeeEngineeringEnvironmental ProtectionFecesFiltrationFrequenciesFundingGoalsHospitalsIncidenceIndividualInfectious Disease EpidemiologyMeasuresMedicalMethodsMicrofluidicsModalityModelingMorbidity - disease rateNew York CityPathogen detectionPatientsPhasePlant ModelPlantsPopulationPopulation DensityPositioning AttributePrecipitationPrevalencePropertyProtocols documentationQuantitative Reverse Transcriptase PCRRADxRADx RadicalRNA VirusesResearchResearch PersonnelSARS-CoV-2 transmissionSafetySalivaSamplingSiteStreamStudentsSurveillance ProgramSystemTest ResultTestingTimeTissue SampleUnited StatesUnited States National Institutes of HealthUniversitiesViralViral Load resultVirus Inactivationbasebetacoronaviruscohortcostcost effectivedetection assaydetection limitdetection sensitivityexperienceimprovedinner cityinnovationmetatranscriptomicsmicrobialmodel buildingmortalitynanoporenasopharyngeal swabnovelnovel coronavirusnovel strategiespandemic diseasepathogenic viruspoint of carepoint of care testingresearch clinical testingresearch facilityresidenceresponsesocial stigmasurveillance strategytertiary caretransmission processundergraduate studenturban settingviral genomicswastewater surveillancewastewater testingwasting
中文摘要
新型冠状病毒SARS-CoV-2正在导致显著的发病率和死亡率。目前对SARS的处理方法-
CoV-2检测成本高,实施不一致,无法快速识别不断演变的疫情。创新
迫切需要监测项目来更好地测量基线传播动态,
新的局部爆发。基于废水的测试(WBT)有可能使人口水平
监测,触发对急性疫情的早期区域反应,并克服个人检测的障碍
例如耻辱和缺乏机会。因此,WBT可以实现更快,更便宜的病原体检测,
改进人口一级流行率估计数。使用以下方法可靠地捕获这种新型冠状病毒
WBT目前尚未定义。必须考虑废水运输过程中的病毒动力学,
必须在多个尺度上系统地评估WBT与临床试验的关系。在这里,我们建议优化
WBT监测协议的废物流在城市大学校园,包括宿舍,研究
设施和三级保健医院,周围的污水处理厂和废水处理厂。我们会发现
使用qRT-PCR估计SARS-CoV-2的流行率,使用病毒组富集的元转录组学估计
表征病毒多样性。我们将使用规范化的WBT数据对病例计数进行建模,并开发使用点
用于WBT的微流体系统。我们的研究者团队在这项研究中处于独特的地位,他们拥有以下方面的专业知识:
传染病、流行病学、在全国范围内使用WBT进行微生物表征,以及床旁检测
试验.我们将实现三个互补的具体目标。在目标1中,我们将优化(1a)收集,
处理以确定WBT的敏感性和安全性。这包括抓取与复合采样;)过滤与
基于沉淀的富集;和病毒灭活方案。我们将进一步优化规模和频率,
在建筑物/下水道坑、校园、下水道和污水处理厂以及不同频率进行采样(1b)。
将通过qRT-PCR和长读段加标引物富集来确定SARS-CoV-2的存在
元转录组学WBT结果将与临床病例负荷、现有监测队列和
扩大员工监控范围在目标2中。我们将改进SARS-CoV-2病例动态的建模,
外推的WBT数据和站点特定的归一化因子。我们将把模型建筑、校园和
社区一级病例计数与现有的临床发病率数据和校园监测使用合奏
卡尔曼滤波器(EnKF)动态建模结合qRT-PCR和元转录组学数据。我们将
比较归一化方法,考虑废水停留时间、人均病毒载量当量
(PCVLE)和其他废物流参数,以减少模型误差。最后,在目标3中,我们将调整使用点
基于优化的WBT协议,使用微流体测试能力。我们将应用现有的RADx
开发用于SARS-CoV-2检测的光热扩增系统,以优化WBT实践。我们
将开发用于WBT样本的模块化系统,并使用病毒对照确定检测阈值。
英文摘要
The novel coronavirus SARS-CoV-2 is causing significant morbidity and mortality. Current approaches to SARS-
CoV-2 testing are costly, inconsistently implemented, and fail to rapidly identify evolving outbreaks. Innovative
surveillance programs are urgently needed to better measure baseline transmission dynamics and anticipate
new localized outbreaks. Wastewater based testing (WBT) has the potential to enable population level
surveillance, trigger earlier regional responses to acute outbreaks, and overcome barriers to individual testing
such as stigma and lack of access. WBT could therefore enable faster and cheaper pathogen detection and
improve population-level estimates of prevalence. Reliable capture approaches for this novel coronavirus using
WBT are currently undefined. Viral dynamics during wastewater transport must be considered, and correlation
of WBT with clinical testing must be systematically evaluated at multiple scales. Here, we propose to optimize
WBT surveillance protocols of waste streams at an urban university campus encompassing dorms, research
facilities and a tertiary care hospital, surrounding sewershed and wastewater treatment plant. We will detect
SARS-CoV-2 using qRT-PCR to estimate prevalence and viral panel-enriched metatranscriptomics to
characterize viral diversity. We will model case counts using normalized WBT data and develop point-of-use
microfluidics systems for WBT. Our team of investigators is uniquely positioned for this study, with expertise in
infectious diseases, epidemiology, microbial characterization using WBT at national scales, and point-of-care
testing. We will implement three complimentary specific aims. In Aim 1, we will optimize (1a) collection and
processing to determine sensitivity and safety of WBT. This includes grab vs. composite sampling;) filtration- vs.
precipitation-based enrichment; and viral inactivation protocols. We will further optimize scale and frequency of
sampling (1b) at the building/sewer pit, campus, sewershed, and WWTP, and across various frequencies.
Presence of SARS-CoV-2 will be ascertained by qRT-PCR and long-read spiked-primer enriched
metatranscriptomics. WBT results will be integrated with clinical case-loads, existing surveillance cohorts and
expanded employee surveillance. In Aim 2. we will improve modeling of SARS-CoV-2 case dynamics using
extrapolated WBT data and site-specific normalization factors. We will correlate modeled building-, campus- and
community-level case counts with existing clinical incidence data and campus surveillance using ensemble
Kalman filter (EnKF) dynamic modeling incorporating both qRT-PCR and metatranscriptomics data. We will
compare normalization methods factoring in wastewater residence time, per capita viral load equivalents
(PCVLEs), and other waste flow parameters to reduce model error. Finally, in Aim 3, we will adapt point-of-use
testing capabilities using microfluidics based on optimized WBT protocols. We will apply existing RADx
development of a photothermal amplification system for SARS-CoV-2 detection to optimized WBT practices. We
will develop a modular system for WBT samples and determine assay detection thresholds using viral controls.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Einstein BSL3 Laboratory Renovation to Advance Biomedical Research on RNA Viruses of Pandemic Potential
-
批准号:10611691
-
项目类别:
-
资助金额:$710.07万
-
财政年份:2022
-
负责人:Kartik Chandran
-
依托单位:
Comprehensive genetic dissection of poxvirus membrane assembly and function
-
批准号:10575027
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2022
-
负责人:Kartik Chandran
-
依托单位:
Optimizing SARS-CoV-2 wastewater based surveillance in urban and university campus settings.
-
批准号:10264634
-
项目类别:
-
资助金额:$244.83万
-
财政年份:2021
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10405068
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10624297
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Structure-based Vaccine Design for CCHFV
-
批准号:10202440
-
项目类别:
-
资助金额:$42.85万
-
财政年份:2020
-
负责人:Kartik Chandran
-
依托单位:
Project II: Biologics Engineering and Antibody Mechanism of Action
-
批准号:10555312
-
项目类别:
-
资助金额:$136.97万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
-
批准号:10088385
-
项目类别:
-
资助金额:$439.05万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core B: Industrialization Core
-
批准号:10088388
-
项目类别:
-
资助金额:$10.18万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project II: Biologics Engineering and Antibody Mechanism of Action
-
批准号:10088393
-
项目类别:
-
资助金额:$166.21万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core A: Administrative Core
-
批准号:10555305
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core A: Administrative Core
-
批准号:10088386
-
项目类别:
-
资助金额:$16.17万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral Threats
-
批准号:10555304
-
项目类别:
-
资助金额:$430.31万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Core B: Industrialization Core
-
批准号:10555307
-
项目类别:
-
资助金额:$115.18万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
In Vivo Efficacy Testing Core
-
批准号:10088390
-
项目类别:
-
资助金额:$71.95万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
In Vivo Efficacy Testing Core
-
批准号:10555309
-
项目类别:
-
资助金额:$136.79万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project I: Discovery and Evaluation of Antibodies and Cocktails
-
批准号:10555311
-
项目类别:
-
资助金额:$101.71万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Project I: Discovery and Evaluation of Antibodies and Cocktails
-
批准号:10088391
-
项目类别:
-
资助金额:$174.54万
-
财政年份:2019
-
负责人:Kartik Chandran
-
依托单位:
Dissecting the receptor-mediated infection mechanisms of hantaviruses
-
批准号:10203768
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2017
-
负责人:Kartik Chandran
-
依托单位:
A "Trojan Horse" bispecific antibody strategy for broad filovirus therapeutics
-
批准号:10192496
-
项目类别:
-
资助金额:$108.42万
-
财政年份:2017
-
负责人:Kartik Chandran
-
依托单位:
海外基金